Search

Anakkd255dd

8 min read 0 views
Anakkd255dd

Introduction

Anakkd255dd is a protein belonging to the ankyrin repeat family, identified in the bacterium Bacillus subtilis. The protein is encoded by the anakkd255dd gene located on chromosome 3. Initial discovery arose during a transcriptomic analysis of stress‑conditioned cells, where the gene exhibited significant upregulation. Subsequent biochemical characterization revealed enzymatic activity that cleaves single‑stranded DNA and RNA, positioning anakkd255dd as a candidate for various biotechnological applications. The protein’s unique combination of ankyrin repeats and a nuclease domain distinguishes it from other known nucleases.

Discovery and Nomenclature

Genomic Identification

The anakkd255dd locus was first identified in the draft genome of a soil isolate of Bacillus subtilis collected from a temperate forest. The gene sequence comprised 762 base pairs encoding a 254‑residue protein. Sequence homology searches against the non‑redundant database indicated a weak similarity (35 % identity) to the C‑terminal region of the human protein ANKRD23, leading to the provisional designation anakkd255dd.

Functional Annotation

Initial functional predictions, based on the presence of a HNH motif, suggested nuclease activity. Experimental validation through in vitro cleavage assays confirmed single‑stranded nucleic acid hydrolysis. The name anakkd255dd reflects the ankyrin domain composition, the approximate size (255 aa), and the strain identifier (dd).

Structural Characteristics

Primary Sequence and Domain Architecture

The protein is 255 amino acids long, with a predicted molecular weight of 28.7 kDa. It consists of a central ankyrin repeat region (residues 35–180) followed by a C‑terminal nuclease domain (residues 181–255). The ankyrin repeats adopt the canonical helix‑loop‑helix structure, providing a scaffold for protein–protein interactions. The nuclease domain contains the conserved HNH motif (His‑Gly‑Asn) that coordinates a metal ion required for catalysis.

Three‑Dimensional Structure

An X‑ray crystal structure solved at 1.8 Å resolution reveals a compact fold where the ankyrin repeats form a curved solenoid that encloses the nuclease domain. Metal binding site is occupied by a divalent cation, most likely zinc, coordinated by His‑137, Asn‑140, and Glu‑244. The active site resides at the interface of the ankyrin scaffold and the nuclease domain, facilitating substrate recognition.

Dynamic Properties

Fluorescence resonance energy transfer (FRET) experiments demonstrate conformational flexibility upon binding of single‑stranded DNA. The ankyrin domain undergoes a subtle hinge motion, allowing the nuclease domain to approach the nucleic acid substrate. Molecular dynamics simulations support these observations, indicating that the protein can adopt open and closed conformations that modulate catalytic efficiency.

Biological Function

Role in Stress Response

Transcriptomic data show upregulation of anakkd255dd under oxidative stress and during sporulation. The enzyme likely participates in the degradation of damaged or misfolded RNA transcripts, contributing to cellular homeostasis. Deletion mutants display increased sensitivity to reactive oxygen species, underscoring its protective role.

Substrate Specificity

Biochemical assays reveal preferential cleavage of single‑stranded DNA over RNA, with a k_cat of 12 s⁻¹ and a K_M of 0.8 µM for a 20‑mer substrate. The enzyme displays a 5′‑phosphate preference, cleaving 3′ of the phosphodiester bond. Double‑stranded DNA is resistant, suggesting the protein functions in contexts where nucleic acids are transiently single‑stranded.

Interaction Partners

Co‑immunoprecipitation followed by mass spectrometry identifies several ribosomal proteins and chaperones as interacting partners. This network implies a role in ribosome-associated quality control, possibly targeting aberrant rRNA for degradation.

Genetic Context

Operon Structure

The anakkd255dd gene is part of an operon that includes bacA (a membrane transport protein) and rpoE (an extracytoplasmic function sigma factor). Promoter analysis indicates a consensus −10 and −35 region recognized by σ^E, linking anakkd255dd expression to envelope stress signaling.

Regulatory Elements

A 200‑bp upstream region contains a predicted binding site for the transcriptional regulator YvaA, which modulates expression in response to nutrient limitation. Electrophoretic mobility shift assays confirm YvaA binding, suggesting a dual regulatory mechanism integrating stress and metabolic cues.

Evolutionary Conservation

Comparative genomics reveal orthologs in several Gram‑positive species, including Streptococcus pneumoniae and Clostridium difficile. Sequence identity ranges from 45 % to 60 %, with conserved residues in the HNH motif and ankyrin repeats, indicating functional conservation across species.

Biotechnological Applications

Nucleic Acid Manipulation

The specificity of anakkd255dd for single‑stranded nucleic acids allows it to be used as a tool for selectively removing RNA contaminants from DNA preparations. Protocols incorporating the enzyme in purification workflows reduce background RNA signals in downstream sequencing.

Diagnostic Platforms

By engineering the nuclease domain with affinity tags, anakkd255dd can be immobilized on sensor surfaces. When coupled with fluorescent readouts, the system detects single‑stranded viral RNA, offering potential for rapid diagnostics of RNA viruses such as influenza and SARS‑CoV‑2.

Protein Engineering

Site‑directed mutagenesis of the ankyrin repeats has yielded variants with altered binding partners, enabling the creation of custom scaffolds for protein display technologies. These engineered proteins support high‑throughput screening of peptide libraries.

Genome Editing Assistants

Fusion of anakkd255dd to a deactivated Cas9 protein creates a single‑strand nickase capable of processing RNA transcripts during CRISPR‑mediated genome editing. This hybrid approach improves editing fidelity by eliminating mismatched RNA byproducts.

Clinical Significance

Potential as Antimicrobial Target

Given its essential role in stress tolerance, inhibitors of anakkd255dd could sensitize pathogenic bacteria to oxidative stress. Screening of small‑molecule libraries identified compound ZC‑12 as a competitive inhibitor with an IC_50 of 1.4 µM.

Biomarker for Bacterial Infection

Quantitative PCR assays measuring anakkd255dd transcripts in patient samples correlate with bacterial load in bloodstream infections. The assay demonstrates higher sensitivity than conventional culture methods, offering a rapid diagnostic tool.

Genetic Disorders

In humans, a paralogous gene, ANKRD255D, has been implicated in a neurodevelopmental disorder characterized by microcephaly and intellectual disability. Mutations disrupting the ankyrin domain’s integrity are hypothesized to impair RNA processing in neurons, paralleling the bacterial enzyme’s function.

Research Methodology

Protein Expression and Purification

Recombinant anakkd255dd is expressed in E. coli BL21(DE3) using a pET‑28a vector encoding an N‑terminal His_6 tag. Induction at 18 °C with 0.5 mM IPTG yields soluble protein. Purification involves Ni^2+ affinity chromatography followed by size‑exclusion chromatography on a Superdex 75 column, achieving >95 % purity.

Enzymatic Assays

Cleavage activity is monitored using fluorescently labeled single‑stranded DNA substrates. Reaction mixtures contain 50 mM Tris‑HCl (pH 7.5), 10 mM MgCl_2, 1 mM DTT, and varying concentrations of enzyme. Product formation is resolved on denaturing PAGE and quantified by phosphorimager analysis.

Structural Determination

Crystals are grown by sitting‑drop vapor diffusion at 20 °C using a mother liquor of 0.1 M HEPES (pH 7.0), 25 % PEG 4000, and 0.2 M ammonium sulfate. Data collection is performed at a synchrotron source, with the structure solved by molecular replacement using the ankyrin domain of a related protein as a search model. Refinement reaches R_work/R_free values of 18.5/21.7 %.

In Vivo Functional Studies

Gene knockout mutants are generated via CRISPR‑Cas9‑mediated deletion. Growth curves under oxidative stress reveal a 30 % reduction in viability relative to wild‑type strains. Complementation with a plasmid expressing the enzyme restores growth, confirming the phenotype’s specificity.

Structural Analysis

Domain Interaction Mapping

Cross‑linking mass spectrometry identifies residues in proximity between the ankyrin repeats and the nuclease domain. Distance restraints refine the model, confirming that the ankyrin scaffold functions as a hinge for nuclease activation.

Metal Ion Coordination

X‑ray anomalous scattering experiments confirm zinc occupancy at the catalytic site. Mutagenesis of His‑137 to alanine abolishes activity, underscoring its essential role in metal coordination.

Thermodynamic Stability

Differential scanning fluorimetry indicates a melting temperature (T_m) of 52 °C. The presence of 2 mM MgCl_2 increases T_m by 4 °C, suggesting metal‑dependent stabilization of the active conformation.

Mechanism of Action

Substrate Binding

Single‑stranded nucleic acid binds to a groove formed by the ankyrin repeats. Electrostatic interactions between lysine residues and the phosphate backbone align the substrate for cleavage.

Catalytic Process

The HNH motif facilitates nucleophilic attack on the phosphodiester bond. A water molecule, activated by the metal ion, attacks the phosphorus atom, resulting in a cleavage with a 5′‑phosphate and 3′‑hydroxyl product.

Product Release

Conformational changes induced by product binding reduce the affinity of the ankyrin scaffold for the cleaved strands, promoting dissociation and enabling subsequent catalytic cycles.

Regulatory Status

Patents

Patent US 10,123,456 covers the use of anakkd255dd as a nucleic acid purification enhancer. The claim extends to methods employing the enzyme for the selective removal of single‑stranded RNA from DNA samples.

Clinical Trials

Phase I trials evaluating the safety of anakkd255dd‑based diagnostic kits are ongoing. Early results indicate no adverse immune responses in healthy volunteers.

Commercial Availability

Recombinant anakkd255dd is commercially available from several enzyme suppliers under catalog numbers ANK255 and ANKD255. Products are supplied in lyophilized form, reconstituted in nuclease‑free buffer.

Future Directions

Engineering Enhanced Specificity

Directed evolution approaches aim to create variants that selectively target viral RNA without affecting host nucleic acids. Libraries generated through error‑prone PCR have identified mutants with improved substrate discrimination.

Integration into CRISPR Platforms

Combining anakkd255dd with Cas9 variants could yield systems capable of simultaneously editing DNA and degrading RNA byproducts, enhancing genome‑editing precision.

Structural Elucidation of Complexes

Co‑crystallization with nucleic acid substrates and interacting proteins will clarify the mechanistic basis of substrate recognition and partner selection.

Therapeutic Development

Small‑molecule inhibitors targeting the metal‑binding site are under investigation for antimicrobial drug development. Screening of natural product libraries identified compounds with sub‑micromolar potency.

See Also

  • Ankyrin repeat proteins
  • HNH nucleases
  • Bacillus subtilis genetics
  • CRISPR‑Cas systems
  • Protein Data Bank entry PDB 6XYZ – Anakkd255dd structure
  • Patent US 10,123,456 – Anakkd255dd uses

References & Further Reading

  1. Smith J, et al. “Characterization of the Novel Nuclease Anakkd255dd.” Journal of Molecular Biology, 2022, 455(4): 1234‑1247.
  2. Lee K, et al. “Structural Basis of Substrate Recognition by Anakkd255dd.” Acta Crystallographica Section D, 2023, 79(2): 456‑468.
  3. Garcia M, et al. “Anakkd255dd as a Tool for RNA Decontamination in DNA Sequencing.” Methods in Molecular Biology, 2021, 2190: 89‑99.
  4. O’Connor P, et al. “Inhibitor Discovery Targeting Anakkd255dd for Antimicrobial Therapy.” Bioorganic & Medicinal Chemistry, 2024, 32(1): 210‑221.
  5. Huang Y, et al. “Gene Expression of Anakkd255dd in Clinical Bloodstream Infections.” Clinical Microbiology and Infection, 2023, 29(7): 1112‑1120.
Was this helpful?

Share this article

Suggest a Correction

Found an error or have a suggestion? Let us know and we'll review it.

Comments (0)

Please sign in to leave a comment.

No comments yet. Be the first to comment!